Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Arrest | 94 | 2023 | 1470 | 12.890 |
Why?
|
Cardiopulmonary Resuscitation | 81 | 2023 | 980 | 11.360 |
Why?
|
Out-of-Hospital Cardiac Arrest | 48 | 2023 | 339 | 9.720 |
Why?
|
Thiamine | 25 | 2024 | 152 | 7.050 |
Why?
|
Shock, Septic | 22 | 2024 | 775 | 6.040 |
Why?
|
Lactic Acid | 26 | 2023 | 1133 | 5.450 |
Why?
|
Hypothermia, Induced | 28 | 2023 | 752 | 5.140 |
Why?
|
Pyruvate Dehydrogenase Complex | 7 | 2018 | 57 | 3.370 |
Why?
|
Vasoconstrictor Agents | 18 | 2022 | 642 | 3.320 |
Why?
|
Sepsis | 28 | 2024 | 2593 | 2.920 |
Why?
|
Ubiquinone | 6 | 2021 | 188 | 2.620 |
Why?
|
Thiamine Deficiency | 6 | 2024 | 43 | 2.560 |
Why?
|
Epinephrine | 14 | 2021 | 792 | 2.530 |
Why?
|
Emergency Medical Services | 28 | 2023 | 1917 | 2.510 |
Why?
|
Cytochromes c | 5 | 2019 | 180 | 2.020 |
Why?
|
Diabetic Ketoacidosis | 5 | 2024 | 245 | 1.920 |
Why?
|
Hospital Mortality | 39 | 2022 | 5317 | 1.760 |
Why?
|
Coma | 6 | 2023 | 475 | 1.630 |
Why?
|
Critical Care | 12 | 2024 | 2647 | 1.580 |
Why?
|
Adrenergic beta-Agonists | 5 | 2016 | 346 | 1.530 |
Why?
|
Intensive Care Units | 17 | 2021 | 3679 | 1.520 |
Why?
|
Neuromuscular Blockade | 3 | 2020 | 146 | 1.520 |
Why?
|
Body Temperature | 8 | 2021 | 777 | 1.420 |
Why?
|
Rewarming | 5 | 2021 | 61 | 1.360 |
Why?
|
Acidosis, Lactic | 6 | 2014 | 142 | 1.230 |
Why?
|
Severity of Illness Index | 17 | 2021 | 15540 | 1.220 |
Why?
|
Electric Countershock | 12 | 2019 | 534 | 1.210 |
Why?
|
Anti-Arrhythmia Agents | 9 | 2020 | 789 | 1.190 |
Why?
|
Respiratory Insufficiency | 9 | 2017 | 1199 | 1.160 |
Why?
|
Respiratory Rate | 4 | 2018 | 162 | 1.130 |
Why?
|
American Heart Association | 13 | 2023 | 1056 | 1.120 |
Why?
|
Positive-Pressure Respiration | 4 | 2013 | 633 | 1.110 |
Why?
|
Community-Acquired Infections | 3 | 2019 | 465 | 1.090 |
Why?
|
Resuscitation | 7 | 2022 | 658 | 1.070 |
Why?
|
Leukocytes, Mononuclear | 4 | 2018 | 1836 | 1.060 |
Why?
|
Emergency Service, Hospital | 29 | 2020 | 7659 | 1.030 |
Why?
|
Intubation, Intratracheal | 8 | 2019 | 1364 | 0.980 |
Why?
|
Oxygen Consumption | 9 | 2023 | 1869 | 0.960 |
Why?
|
Shock | 4 | 2019 | 318 | 0.950 |
Why?
|
Pulmonary Embolism | 5 | 2020 | 2376 | 0.950 |
Why?
|
Hypotension | 6 | 2021 | 884 | 0.930 |
Why?
|
Humans | 236 | 2024 | 744343 | 0.900 |
Why?
|
Respiration, Artificial | 14 | 2023 | 2569 | 0.890 |
Why?
|
Middle Aged | 122 | 2023 | 213383 | 0.890 |
Why?
|
Coronary Artery Bypass | 5 | 2018 | 2289 | 0.880 |
Why?
|
Critical Illness | 8 | 2023 | 2670 | 0.870 |
Why?
|
Male | 152 | 2023 | 350118 | 0.850 |
Why?
|
Aged | 107 | 2022 | 163280 | 0.850 |
Why?
|
Ascorbic Acid | 4 | 2020 | 651 | 0.830 |
Why?
|
Propanolamines | 1 | 2022 | 167 | 0.800 |
Why?
|
Female | 151 | 2023 | 380194 | 0.790 |
Why?
|
Vitamin B Complex | 5 | 2017 | 288 | 0.770 |
Why?
|
APACHE | 4 | 2021 | 277 | 0.760 |
Why?
|
Acute Kidney Injury | 5 | 2023 | 1972 | 0.760 |
Why?
|
Hypothermia | 3 | 2015 | 189 | 0.740 |
Why?
|
Ventricular Fibrillation | 7 | 2020 | 538 | 0.710 |
Why?
|
Registries | 31 | 2022 | 8089 | 0.710 |
Why?
|
Adrenergic alpha-Agonists | 3 | 2016 | 177 | 0.700 |
Why?
|
Prone Position | 1 | 2020 | 194 | 0.700 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2020 | 147 | 0.700 |
Why?
|
Nervous System Diseases | 6 | 2018 | 1622 | 0.680 |
Why?
|
Alcoholism | 2 | 2021 | 1906 | 0.670 |
Why?
|
Advanced Cardiac Life Support | 3 | 2020 | 70 | 0.670 |
Why?
|
Prospective Studies | 48 | 2024 | 53288 | 0.670 |
Why?
|
Blood Circulation | 4 | 2017 | 251 | 0.660 |
Why?
|
Influenza, Human | 2 | 2021 | 1479 | 0.650 |
Why?
|
Retrospective Studies | 56 | 2022 | 77449 | 0.640 |
Why?
|
Patient Positioning | 1 | 2020 | 324 | 0.620 |
Why?
|
Perioperative Care | 2 | 2015 | 1002 | 0.620 |
Why?
|
Fluid Therapy | 5 | 2015 | 593 | 0.620 |
Why?
|
Brain Edema | 2 | 2014 | 617 | 0.610 |
Why?
|
Intubation | 2 | 2017 | 141 | 0.610 |
Why?
|
Pneumonia | 3 | 2019 | 2133 | 0.590 |
Why?
|
Creatinine | 3 | 2023 | 1919 | 0.590 |
Why?
|
Wernicke Encephalopathy | 2 | 2007 | 28 | 0.590 |
Why?
|
Hydrocortisone | 5 | 2024 | 1826 | 0.590 |
Why?
|
Informed Consent | 1 | 2023 | 995 | 0.580 |
Why?
|
Vomiting | 2 | 2010 | 636 | 0.580 |
Why?
|
Aged, 80 and over | 45 | 2020 | 57776 | 0.570 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2021 | 632 | 0.570 |
Why?
|
Practice Guidelines as Topic | 18 | 2019 | 7279 | 0.570 |
Why?
|
Fever | 3 | 2015 | 1616 | 0.550 |
Why?
|
Marijuana Abuse | 2 | 2010 | 403 | 0.540 |
Why?
|
Guidelines as Topic | 2 | 2019 | 1405 | 0.540 |
Why?
|
Pulse | 2 | 2018 | 229 | 0.540 |
Why?
|
Double-Blind Method | 16 | 2024 | 12026 | 0.540 |
Why?
|
Cause of Death | 5 | 2019 | 3584 | 0.510 |
Why?
|
Vasopressins | 3 | 2021 | 370 | 0.500 |
Why?
|
Survival Analysis | 15 | 2020 | 10252 | 0.500 |
Why?
|
Treatment Outcome | 38 | 2024 | 63114 | 0.490 |
Why?
|
Adult | 68 | 2023 | 214055 | 0.480 |
Why?
|
Glycolysis | 1 | 2018 | 827 | 0.480 |
Why?
|
Survival Rate | 20 | 2021 | 12788 | 0.470 |
Why?
|
Wakefulness | 1 | 2020 | 1245 | 0.460 |
Why?
|
Mouth Floor | 1 | 2013 | 34 | 0.460 |
Why?
|
Hemodynamics | 4 | 2022 | 4199 | 0.460 |
Why?
|
Plethysmography, Whole Body | 1 | 2013 | 24 | 0.460 |
Why?
|
Withholding Treatment | 2 | 2019 | 599 | 0.450 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1855 | 0.450 |
Why?
|
Carbon Dioxide | 5 | 2023 | 1150 | 0.440 |
Why?
|
Amiodarone | 5 | 2020 | 212 | 0.440 |
Why?
|
Ventricular Function | 1 | 2014 | 416 | 0.440 |
Why?
|
Survivors | 9 | 2023 | 2291 | 0.440 |
Why?
|
Time Factors | 21 | 2020 | 40075 | 0.420 |
Why?
|
Micronutrients | 1 | 2015 | 375 | 0.420 |
Why?
|
Prognosis | 23 | 2021 | 29063 | 0.410 |
Why?
|
Lung Volume Measurements | 1 | 2013 | 378 | 0.410 |
Why?
|
Hospitalization | 15 | 2021 | 10262 | 0.410 |
Why?
|
Consensus | 11 | 2023 | 2959 | 0.410 |
Why?
|
Hospitals, Teaching | 2 | 2017 | 1179 | 0.400 |
Why?
|
Predictive Value of Tests | 16 | 2018 | 15076 | 0.400 |
Why?
|
Bacteremia | 4 | 2012 | 962 | 0.400 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 817 | 0.400 |
Why?
|
Patient Discharge | 14 | 2021 | 3313 | 0.400 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 316 | 0.400 |
Why?
|
Cardiology | 5 | 2020 | 1668 | 0.390 |
Why?
|
Airway Management | 4 | 2019 | 329 | 0.390 |
Why?
|
Myoclonus | 1 | 2011 | 104 | 0.390 |
Why?
|
Logistic Models | 17 | 2019 | 13408 | 0.380 |
Why?
|
Emergencies | 4 | 2020 | 1170 | 0.380 |
Why?
|
ROC Curve | 7 | 2018 | 3527 | 0.380 |
Why?
|
Lactates | 3 | 2023 | 432 | 0.380 |
Why?
|
Regional Health Planning | 1 | 2011 | 97 | 0.380 |
Why?
|
Acid-Base Imbalance | 2 | 2009 | 41 | 0.370 |
Why?
|
Kidney | 4 | 2024 | 7186 | 0.370 |
Why?
|
United States | 37 | 2022 | 69872 | 0.370 |
Why?
|
Length of Stay | 2 | 2015 | 6309 | 0.360 |
Why?
|
Pilot Projects | 7 | 2017 | 8324 | 0.360 |
Why?
|
Nausea | 2 | 2010 | 673 | 0.360 |
Why?
|
Defibrillators | 3 | 2020 | 37 | 0.360 |
Why?
|
Vitamins | 3 | 2014 | 1622 | 0.350 |
Why?
|
Critical Pathways | 1 | 2013 | 476 | 0.350 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 941 | 0.340 |
Why?
|
Acute Disease | 8 | 2024 | 7149 | 0.340 |
Why?
|
Flank Pain | 1 | 2009 | 43 | 0.340 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1257 | 0.340 |
Why?
|
Microcirculation | 1 | 2013 | 1286 | 0.330 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1541 | 0.320 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 788 | 0.320 |
Why?
|
Angiography | 1 | 2013 | 1639 | 0.310 |
Why?
|
Biomedical Research | 1 | 2023 | 3309 | 0.310 |
Why?
|
Postoperative Complications | 4 | 2016 | 15295 | 0.300 |
Why?
|
Central Venous Pressure | 1 | 2007 | 78 | 0.300 |
Why?
|
Marijuana Smoking | 1 | 2010 | 253 | 0.300 |
Why?
|
Models, Organizational | 1 | 2011 | 574 | 0.300 |
Why?
|
Cannabinoids | 1 | 2009 | 166 | 0.290 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 1573 | 0.290 |
Why?
|
Rhabdomyolysis | 1 | 2007 | 150 | 0.280 |
Why?
|
Leukocyte Count | 1 | 2010 | 1588 | 0.280 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5751 | 0.280 |
Why?
|
Hospitals, Urban | 5 | 2012 | 499 | 0.280 |
Why?
|
Monitoring, Physiologic | 5 | 2019 | 1738 | 0.280 |
Why?
|
Blood Specimen Collection | 1 | 2007 | 246 | 0.270 |
Why?
|
Lidocaine | 5 | 2020 | 544 | 0.270 |
Why?
|
Beriberi | 1 | 2004 | 6 | 0.260 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2024 | 9959 | 0.260 |
Why?
|
Cardiovascular Agents | 3 | 2021 | 850 | 0.260 |
Why?
|
Oxygen | 3 | 2018 | 4189 | 0.250 |
Why?
|
Advisory Committees | 4 | 2018 | 775 | 0.250 |
Why?
|
Atropine | 3 | 2020 | 244 | 0.250 |
Why?
|
Pulmonary Artery | 1 | 2013 | 1912 | 0.250 |
Why?
|
Recovery of Function | 4 | 2018 | 2925 | 0.250 |
Why?
|
Cohort Studies | 19 | 2020 | 40561 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 7 | 2014 | 20129 | 0.250 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 855 | 0.240 |
Why?
|
Anti-Bacterial Agents | 4 | 2020 | 7181 | 0.240 |
Why?
|
Cannabis | 1 | 2010 | 439 | 0.240 |
Why?
|
Emergency Treatment | 5 | 2023 | 517 | 0.230 |
Why?
|
Mitochondria | 1 | 2017 | 3520 | 0.230 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2274 | 0.230 |
Why?
|
Calcitriol | 2 | 2014 | 298 | 0.220 |
Why?
|
Tidal Volume | 2 | 2017 | 490 | 0.220 |
Why?
|
Dog Diseases | 1 | 2023 | 138 | 0.220 |
Why?
|
Risk Assessment | 9 | 2018 | 23338 | 0.220 |
Why?
|
Blood Gas Analysis | 4 | 2018 | 383 | 0.220 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2010 | 1018 | 0.210 |
Why?
|
Patient Care Team | 1 | 2013 | 2531 | 0.210 |
Why?
|
Cytokines | 3 | 2016 | 7322 | 0.200 |
Why?
|
Stroke Volume | 1 | 2014 | 5007 | 0.200 |
Why?
|
Multiple Organ Failure | 3 | 2020 | 390 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2015 | 3255 | 0.200 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2731 | 0.200 |
Why?
|
Glucocorticoids | 2 | 2021 | 2107 | 0.200 |
Why?
|
Magnesium | 3 | 2019 | 813 | 0.190 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39050 | 0.190 |
Why?
|
Pregnancy Complications, Cardiovascular | 3 | 2015 | 500 | 0.190 |
Why?
|
Interleukins | 2 | 2016 | 791 | 0.190 |
Why?
|
Guideline Adherence | 4 | 2019 | 2266 | 0.190 |
Why?
|
Area Under Curve | 7 | 2018 | 1654 | 0.190 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 707 | 0.190 |
Why?
|
Hospitals | 8 | 2022 | 3952 | 0.190 |
Why?
|
Tachycardia, Ventricular | 3 | 2018 | 1273 | 0.190 |
Why?
|
Statistics, Nonparametric | 3 | 2018 | 2886 | 0.180 |
Why?
|
Troponin I | 1 | 2004 | 619 | 0.180 |
Why?
|
Young Adult | 12 | 2022 | 56430 | 0.180 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2400 | 0.180 |
Why?
|
Triage | 4 | 2009 | 976 | 0.180 |
Why?
|
Methylprednisolone | 1 | 2021 | 387 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 3537 | 0.180 |
Why?
|
Internationality | 2 | 2015 | 1003 | 0.180 |
Why?
|
Glasgow Coma Scale | 3 | 2017 | 570 | 0.180 |
Why?
|
Hospitals, Pediatric | 5 | 2022 | 1775 | 0.170 |
Why?
|
Adolescent | 18 | 2021 | 85781 | 0.170 |
Why?
|
Tachycardia | 1 | 2022 | 619 | 0.170 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2015 | 333 | 0.170 |
Why?
|
Norepinephrine | 1 | 2022 | 909 | 0.170 |
Why?
|
Comorbidity | 7 | 2017 | 10388 | 0.170 |
Why?
|
Life Support Care | 1 | 2020 | 228 | 0.170 |
Why?
|
Receptors, Purinergic P2X1 | 1 | 2018 | 8 | 0.170 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2019 | 88 | 0.170 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1677 | 0.170 |
Why?
|
Inflammation | 4 | 2024 | 10638 | 0.170 |
Why?
|
Organizational Case Studies | 1 | 2019 | 299 | 0.160 |
Why?
|
Sensitivity and Specificity | 6 | 2017 | 14722 | 0.160 |
Why?
|
Residence Characteristics | 2 | 2019 | 2050 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 246 | 0.160 |
Why?
|
Heart Failure | 2 | 2019 | 10900 | 0.160 |
Why?
|
Anaerobiosis | 1 | 2018 | 140 | 0.160 |
Why?
|
Odds Ratio | 9 | 2019 | 9849 | 0.160 |
Why?
|
Vital Signs | 2 | 2017 | 142 | 0.160 |
Why?
|
Child | 19 | 2023 | 77709 | 0.150 |
Why?
|
Ribonuclease P | 1 | 2017 | 17 | 0.150 |
Why?
|
Mitochondria, Heart | 1 | 2019 | 247 | 0.150 |
Why?
|
Uremia | 1 | 2018 | 201 | 0.150 |
Why?
|
Benzoates | 1 | 2019 | 217 | 0.150 |
Why?
|
Brain Ischemia | 1 | 2011 | 3265 | 0.150 |
Why?
|
Quality of Health Care | 3 | 2013 | 4371 | 0.150 |
Why?
|
Hypercapnia | 1 | 2018 | 260 | 0.150 |
Why?
|
Hyperthermia, Induced | 2 | 2019 | 403 | 0.150 |
Why?
|
Hematocrit | 1 | 2018 | 636 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2017 | 21746 | 0.140 |
Why?
|
Pancreatitis | 1 | 2024 | 1092 | 0.140 |
Why?
|
Calcitonin | 1 | 2018 | 336 | 0.140 |
Why?
|
Personnel Turnover | 1 | 2017 | 83 | 0.140 |
Why?
|
Pregnancy Complications | 1 | 2011 | 2861 | 0.140 |
Why?
|
Pyrimidinones | 1 | 2019 | 371 | 0.140 |
Why?
|
Inpatients | 3 | 2019 | 2518 | 0.140 |
Why?
|
Catheterization, Central Venous | 2 | 2015 | 514 | 0.140 |
Why?
|
Balloon Occlusion | 1 | 2017 | 126 | 0.140 |
Why?
|
Confusion | 1 | 2018 | 275 | 0.140 |
Why?
|
Pulmonary Gas Exchange | 1 | 2018 | 382 | 0.140 |
Why?
|
Near Drowning | 1 | 2015 | 12 | 0.140 |
Why?
|
Gastrointestinal Diseases | 1 | 2004 | 1170 | 0.140 |
Why?
|
Culture Media | 1 | 2018 | 908 | 0.140 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2018 | 1354 | 0.140 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2017 | 188 | 0.140 |
Why?
|
Protective Agents | 1 | 2017 | 156 | 0.140 |
Why?
|
Coronary Care Units | 1 | 2017 | 214 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2016 | 3508 | 0.140 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6489 | 0.140 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2015 | 367 | 0.130 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.130 |
Why?
|
Infant | 12 | 2020 | 35136 | 0.130 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 202 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2018 | 612 | 0.130 |
Why?
|
Hyperoxia | 1 | 2018 | 262 | 0.130 |
Why?
|
Blood Pressure | 3 | 2019 | 8554 | 0.130 |
Why?
|
Propensity Score | 6 | 2019 | 1781 | 0.130 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 730 | 0.130 |
Why?
|
Injections, Intravenous | 2 | 2014 | 1420 | 0.130 |
Why?
|
Risk Factors | 15 | 2020 | 72290 | 0.130 |
Why?
|
Child, Preschool | 12 | 2020 | 41006 | 0.130 |
Why?
|
Esophageal and Gastric Varices | 1 | 2017 | 207 | 0.130 |
Why?
|
Infant, Newborn | 9 | 2023 | 25625 | 0.130 |
Why?
|
Medical Futility | 1 | 2016 | 127 | 0.130 |
Why?
|
Quality Improvement | 4 | 2019 | 3749 | 0.130 |
Why?
|
Hyperglycemia | 3 | 2021 | 1373 | 0.120 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2015 | 113 | 0.120 |
Why?
|
Disease Management | 2 | 2015 | 2459 | 0.120 |
Why?
|
Cardiac Tamponade | 1 | 2015 | 173 | 0.120 |
Why?
|
Hospitals, University | 3 | 2012 | 571 | 0.120 |
Why?
|
Angiopoietin-2 | 1 | 2015 | 173 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4420 | 0.120 |
Why?
|
Incidence | 5 | 2019 | 20947 | 0.120 |
Why?
|
Bacterial Infections | 2 | 2020 | 1401 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10943 | 0.120 |
Why?
|
Magnesium Deficiency | 1 | 2014 | 47 | 0.120 |
Why?
|
Cardiac Care Facilities | 1 | 2013 | 35 | 0.120 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12245 | 0.110 |
Why?
|
Nitric Oxide | 2 | 2019 | 2132 | 0.110 |
Why?
|
Emergency Medicine | 4 | 2007 | 1207 | 0.110 |
Why?
|
PubMed | 1 | 2013 | 123 | 0.110 |
Why?
|
Naloxone | 1 | 2015 | 367 | 0.110 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5319 | 0.110 |
Why?
|
First Aid | 2 | 2023 | 65 | 0.110 |
Why?
|
Myocardial Infarction | 3 | 2023 | 11727 | 0.110 |
Why?
|
Renal Dialysis | 2 | 2017 | 1786 | 0.110 |
Why?
|
Hot Temperature | 1 | 2018 | 1354 | 0.110 |
Why?
|
Simvastatin | 1 | 2015 | 360 | 0.110 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2015 | 321 | 0.110 |
Why?
|
Viral Load | 1 | 2021 | 3299 | 0.100 |
Why?
|
Patients | 1 | 2019 | 900 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18029 | 0.100 |
Why?
|
Confidence Intervals | 2 | 2021 | 2971 | 0.100 |
Why?
|
Kidney Failure, Chronic | 1 | 2004 | 2538 | 0.100 |
Why?
|
Random Allocation | 1 | 2016 | 2429 | 0.100 |
Why?
|
Arctic Regions | 1 | 2011 | 25 | 0.100 |
Why?
|
Dentures | 1 | 2010 | 11 | 0.100 |
Why?
|
Treatment Failure | 2 | 2020 | 2618 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2019 | 1827 | 0.100 |
Why?
|
Resuscitation Orders | 1 | 2013 | 269 | 0.100 |
Why?
|
Cell-Derived Microparticles | 1 | 2013 | 168 | 0.100 |
Why?
|
Partial Pressure | 3 | 2018 | 254 | 0.100 |
Why?
|
Qualitative Research | 1 | 2019 | 2682 | 0.090 |
Why?
|
Massachusetts | 4 | 2019 | 8663 | 0.090 |
Why?
|
Baths | 1 | 2010 | 54 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 961 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8388 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2373 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3778 | 0.090 |
Why?
|
Apyrase | 1 | 2013 | 364 | 0.090 |
Why?
|
Dogs | 2 | 2023 | 3912 | 0.090 |
Why?
|
Cross Infection | 2 | 2020 | 1416 | 0.090 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2010 | 143 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1130 | 0.090 |
Why?
|
Pulmonary Edema | 1 | 2012 | 414 | 0.090 |
Why?
|
Coronary Disease | 1 | 2004 | 6077 | 0.090 |
Why?
|
Vertigo | 1 | 2011 | 202 | 0.090 |
Why?
|
Data Collection | 3 | 2019 | 3341 | 0.090 |
Why?
|
Urban Health Services | 1 | 2010 | 179 | 0.080 |
Why?
|
Facial Injuries | 1 | 2010 | 183 | 0.080 |
Why?
|
Interleukin-2 | 1 | 2016 | 1904 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2013 | 380 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2021 | 3297 | 0.080 |
Why?
|
Risk | 3 | 2016 | 9687 | 0.080 |
Why?
|
Calibration | 1 | 2011 | 816 | 0.080 |
Why?
|
Body Temperature Regulation | 2 | 2021 | 252 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2268 | 0.080 |
Why?
|
Anaphylaxis | 1 | 2015 | 746 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 21827 | 0.080 |
Why?
|
Delirium | 1 | 2019 | 1609 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 5882 | 0.080 |
Why?
|
Observation | 1 | 2010 | 312 | 0.080 |
Why?
|
Coronary Angiography | 2 | 2017 | 4577 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.080 |
Why?
|
Hypovolemia | 1 | 2007 | 45 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.070 |
Why?
|
Algorithms | 2 | 2015 | 13881 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12354 | 0.070 |
Why?
|
Glucose | 2 | 2019 | 4397 | 0.070 |
Why?
|
Linear Models | 2 | 2015 | 5952 | 0.070 |
Why?
|
Patient Transfer | 1 | 2013 | 761 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2010 | 399 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2917 | 0.070 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3057 | 0.070 |
Why?
|
Anti-Asthmatic Agents | 1 | 2010 | 536 | 0.070 |
Why?
|
Patient Preference | 1 | 2013 | 890 | 0.070 |
Why?
|
Adrenal Insufficiency | 1 | 2007 | 184 | 0.070 |
Why?
|
Shock, Hemorrhagic | 1 | 2007 | 220 | 0.070 |
Why?
|
Heart Rate | 2 | 2014 | 4091 | 0.070 |
Why?
|
Heart | 1 | 2019 | 4467 | 0.070 |
Why?
|
New Jersey | 1 | 2005 | 290 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4215 | 0.060 |
Why?
|
Tobacco Use Disorder | 1 | 2010 | 688 | 0.060 |
Why?
|
Physical Exertion | 1 | 2007 | 695 | 0.060 |
Why?
|
Wounds, Gunshot | 1 | 2010 | 563 | 0.060 |
Why?
|
Glycoproteins | 1 | 2013 | 2263 | 0.060 |
Why?
|
Animals | 10 | 2023 | 168757 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.060 |
Why?
|
Asthma | 3 | 2012 | 6011 | 0.060 |
Why?
|
Pregnancy | 4 | 2015 | 29144 | 0.060 |
Why?
|
Thiamine Pyrophosphate | 1 | 2023 | 9 | 0.060 |
Why?
|
Databases, Factual | 2 | 2017 | 7729 | 0.060 |
Why?
|
Attitude to Health | 1 | 2013 | 2052 | 0.060 |
Why?
|
Gram-Negative Bacteria | 2 | 2018 | 270 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2737 | 0.060 |
Why?
|
Age Factors | 3 | 2016 | 18370 | 0.060 |
Why?
|
Hippocampus | 1 | 2016 | 3675 | 0.060 |
Why?
|
Liver Diseases | 1 | 2012 | 1253 | 0.060 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2023 | 135 | 0.050 |
Why?
|
Syncope | 1 | 2006 | 429 | 0.050 |
Why?
|
Cardiac Output | 1 | 2005 | 854 | 0.050 |
Why?
|
Wounds, Nonpenetrating | 1 | 2009 | 794 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10481 | 0.050 |
Why?
|
Antigens, CD | 1 | 2013 | 4026 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.050 |
Why?
|
Cocaine | 1 | 2007 | 1007 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9583 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2356 | 0.050 |
Why?
|
Boston | 3 | 2020 | 9313 | 0.050 |
Why?
|
Age Distribution | 2 | 2019 | 2902 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1177 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3396 | 0.050 |
Why?
|
Peptides | 1 | 2013 | 4409 | 0.050 |
Why?
|
Head | 1 | 2006 | 880 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2007 | 2453 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 82 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2023 | 1572 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5708 | 0.040 |
Why?
|
Respiratory Function Tests | 2 | 2018 | 1616 | 0.040 |
Why?
|
Denmark | 1 | 2021 | 738 | 0.040 |
Why?
|
Extracorporeal Circulation | 1 | 2019 | 182 | 0.040 |
Why?
|
Mice | 5 | 2019 | 81183 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8642 | 0.040 |
Why?
|
Hyponatremia | 1 | 2021 | 298 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2010 | 2838 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.040 |
Why?
|
Syndrome | 1 | 2004 | 3251 | 0.040 |
Why?
|
Early Diagnosis | 2 | 2017 | 1184 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2021 | 930 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2018 | 170 | 0.040 |
Why?
|
Bicarbonates | 1 | 2019 | 313 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3047 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2019 | 645 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2010 | 3748 | 0.040 |
Why?
|
Gram-Positive Bacteria | 1 | 2018 | 184 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 5987 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 513 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1676 | 0.040 |
Why?
|
Stroke | 3 | 2019 | 9981 | 0.040 |
Why?
|
Temperature | 1 | 2023 | 2206 | 0.040 |
Why?
|
Regression Analysis | 2 | 2017 | 6459 | 0.040 |
Why?
|
Acidosis | 1 | 2018 | 270 | 0.040 |
Why?
|
Uncertainty | 1 | 2021 | 734 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2011 | 4234 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 549 | 0.030 |
Why?
|
Heart Massage | 1 | 2015 | 30 | 0.030 |
Why?
|
Hospital Units | 1 | 2016 | 141 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2018 | 292 | 0.030 |
Why?
|
Surgery Department, Hospital | 1 | 2017 | 175 | 0.030 |
Why?
|
Pennsylvania | 1 | 2016 | 613 | 0.030 |
Why?
|
Telemetry | 1 | 2016 | 205 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3658 | 0.030 |
Why?
|
Brain Damage, Chronic | 1 | 2015 | 265 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15165 | 0.030 |
Why?
|
Systems Analysis | 1 | 2015 | 172 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2002 | 1411 | 0.030 |
Why?
|
Cathelicidins | 1 | 2014 | 80 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 345 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 1959 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1413 | 0.030 |
Why?
|
Hospitalists | 1 | 2018 | 305 | 0.030 |
Why?
|
Child, Hospitalized | 1 | 2015 | 174 | 0.030 |
Why?
|
Republic of Korea | 1 | 2015 | 539 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12959 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1025 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2018 | 3589 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2187 | 0.030 |
Why?
|
Judgment | 1 | 2015 | 281 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2015 | 229 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1842 | 0.030 |
Why?
|
Electrocardiography | 2 | 2017 | 6442 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2019 | 1572 | 0.030 |
Why?
|
Obesity | 2 | 2012 | 12745 | 0.030 |
Why?
|
Swine | 1 | 2023 | 5917 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1420 | 0.030 |
Why?
|
Hypoxia, Brain | 1 | 2013 | 133 | 0.030 |
Why?
|
Bacterial Toxins | 1 | 2018 | 931 | 0.030 |
Why?
|
Tissue and Organ Harvesting | 1 | 2015 | 369 | 0.030 |
Why?
|
Public-Private Sector Partnerships | 1 | 2013 | 121 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 2017 | 1066 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2014 | 362 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2017 | 867 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2018 | 981 | 0.020 |
Why?
|
Dyspnea | 1 | 2019 | 1303 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3870 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1683 | 0.020 |
Why?
|
Patient Admission | 1 | 2018 | 1380 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 661 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20822 | 0.020 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2012 | 232 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2019 | 1580 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 690 | 0.020 |
Why?
|
Respiratory Aspiration | 1 | 2010 | 81 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 397 | 0.020 |
Why?
|
Acetaminophen | 1 | 2013 | 545 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3610 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4297 | 0.020 |
Why?
|
Cosyntropin | 1 | 2007 | 33 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2015 | 896 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3743 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2010 | 1014 | 0.020 |
Why?
|
Population Surveillance | 1 | 2018 | 2616 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2029 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2010 | 1850 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2015 | 1916 | 0.020 |
Why?
|
Calcium | 1 | 2019 | 5756 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 687 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8340 | 0.020 |
Why?
|
Urea | 1 | 2007 | 450 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4456 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2007 | 1681 | 0.020 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2005 | 86 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5391 | 0.020 |
Why?
|
Vitamin D | 1 | 2018 | 3223 | 0.020 |
Why?
|
Forecasting | 1 | 2013 | 2951 | 0.010 |
Why?
|
Administration, Oral | 1 | 2012 | 3913 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4034 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14557 | 0.010 |
Why?
|
Hormones | 1 | 2007 | 889 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 2007 | 634 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2278 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1400 | 0.010 |
Why?
|
Seizures | 1 | 2015 | 2859 | 0.010 |
Why?
|
Perfusion | 1 | 2007 | 1360 | 0.010 |
Why?
|
Models, Statistical | 1 | 2017 | 5102 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 2958 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 2010 | 1221 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2012 | 2795 | 0.010 |
Why?
|
Rats | 1 | 2018 | 24260 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2505 | 0.010 |
Why?
|
Blood Glucose | 1 | 2015 | 6256 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3386 | 0.010 |
Why?
|
Causality | 1 | 2007 | 1275 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5078 | 0.010 |
Why?
|
Decision Making | 1 | 2013 | 3887 | 0.010 |
Why?
|
Physicians | 1 | 2017 | 4567 | 0.010 |
Why?
|
Liver | 1 | 2013 | 7474 | 0.010 |
Why?
|
Internship and Residency | 1 | 2017 | 5788 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6538 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25043 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 35421 | 0.000 |
Why?
|